Invention Grant
- Patent Title: PBRM1 biomarkers predictive of anti-immune checkpoint response
-
Application No.: US16475574Application Date: 2018-01-03
-
Publication No.: US11377696B2Publication Date: 2022-07-05
- Inventor: Eliezer Van Allen , Diana Miao , Toni K. Choueiri
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- International Application: PCT/US2018/012209 WO 20180103
- International Announcement: WO2018/132287 WO 20180719
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; G01N33/50 ; G01N33/574
Abstract:
The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
Public/Granted literature
- US20190338369A1 PBRM1 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE Public/Granted day:2019-11-07
Information query
IPC分类:
